GABA-activated ligand gated ion channels: Medicinal chemistry and molecular biology

Journal of Medicinal Chemistry

Volumn 43, Issue 8, 2000, Pages 1427-1447

  Chebib, Mary ^a   Johnston, Graham A R ^a  

^a University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; FATTY ACID DERIVATIVE; FLAVONOID; ION CHANNEL; NITRIC OXIDE; THYROID HORMONE;

CHANNEL GATING; CHEMICAL STRUCTURE; LIGAND BINDING; MOLECULAR BIOLOGY; NEUROTRANSMISSION; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; ION CHANNEL GATING; ION CHANNELS; LIGANDS; RECEPTORS, GABA; RECEPTORS, GABA-A; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034692175     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9904349     Document Type: Review

References (199)

1. A receptor agonists, partial agonists, and antagonists. Design and therapeutic prospects. J. Med. Chem. 1994, 37, 2489-2505.
2. A receptor pharmacology. Pharmacol. Ther. 1996, 69, 173-198.
3. A receptor subtypes. Pharmacol. Rev. 1995, 47, 181-234.
4. A receptor subtypes: which, where and why? Sem. Neurosci. 1995, 7, 115-126.
5. A receptor research. Synapse 1995, 21, 189-274.
6. Krogsgaard-Larsen, P.; Frølund, B.; Ebert, B. GABA-A receptor agonists, partial agonists, and antagonists. In The GABA Receptors, 2nd ed.; Enna, S. J., Bowery, N. G., Eds.; Humana: Totowa, NJ, 1997; pp 37-81.
7. A receptor subtypes - clinical efficacy and selectivity of benzodiazepine site ligands. Ann. Med. 1997, 29, 275-282.
8. A receptors - classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 1998, 50, 291-313.
9. Enna, S. J.; Bowery, N. G. The GABA Receptors, 2nd ed.; Humana Press: Totowa, NJ, 1997; p 332.
10. A receptors. Brain Res. Rev. 1999, 29, 196-217.
11. C receptors. Trends Neurosci. 1995, 18, 515-519.
12. C receptors: relatively simple transmitter-gated ion channels? Trends Pharmacol. Sci. 1996, 17, 319-323.
13. C receptors. In The GABA Receptors, 2nd ed.; Enna, S. J., Bowery, N. G., Eds.; Humana: Totowa, NJ, 1997; pp 297-323.
14. C receptors. Vision Res. 1998, 38, 1431-1441.
15. - channels in the rat retina. Prog. Ret. Eye Res. 1998, 17, 99-126.
16. Wassle, H.; Koulen, P.; Brandstatter, J. H.; Fletcher, E. L.; Becker, C. M. Glycine and GABA receptors in the mammalian retina. Vision Res. 1998, 38, 1411-1430.
17. Bikker, J. A.; Trumpp-Kallmeyer, S.; Humblet, C. G-Protein Coupled Receptors: Models, Mutagenesis, and Drug Design. J. Med. Chem. 1998, 41, 2911-2927.
18. Le Novere, N.; Changeux, J. P. The ligand gated ion channel database. Nucl. Acids Res. 1999, 27, 340-342.
19. Le Novere, N.; Changeux, J. P. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J. Mol. Evol. 1995, 40, 155-172.
20. Ortells, M. O.; Lunt, G. G. Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci. 1995, 18, 121-127.
21. Johnston, G. A. R.; Chebib, M.; Duke, R. K.; Mewett, K. N.; Mitrovic, A. D.; Vandenberg, R. J. Medicinal chemistry and molecular pharmacology of GABA receptors and glutamate transporters - complementary structure-activity relationships. Drug Dev. Res. 1999, 46, 255-260.
22. A, and nicotinic acetylcholine receptors provide new insights into the ligand-gated ion channel superfamily. Int. Rev. Neurobiol. 1998, 42, 285-332.
23. A receptor. J. Neurosci. 1998, 18, 8590-8604.
24. C receptor. Nature Neurosci. 1999, 2, 219-225.
25. Colquhoun, D. GABA and the single oocytes: relating binding to gating. Nature Neurosci. 1999, 2, 201-202.
26. C receptors on rat retinal bipolar cells. Eur. J. Pharmacol. 1994, 288, 97-104.
27. - channels in rat retinal bipolar cells. Nature 1993, 361, 159-162.
28. Amin, J.; Weiss, D. S. Homomeric rho 1 GABA channels: activation properties and domains. Recept. Chann. 1994, 2, 227-36.
29. Duke, R. K.; Allan, R. D.; Chebib, M.; Greenwood, J. R.; Johnston, G. A. R. Resolution and conformational analysis of diastereoisomeric esters of cis- and trans-2-(aminomethyl)-1-carboxycyclopropanes. Tetrahedron Asymm. 1998, 9, 2533-2548 and unpublished observations.
30. B receptor agonists and antagonists. Mol. Pharmacol. 1993, 43, 609-625.
31. C receptor antagonist. Mol. Pharmacol. 1996, 50, 1024-1030.
32. Cutting, G. R.; Curristin, S.; Zoghbi, H.; O'Hara, B.; Seldin, M. F.; Uhl, G. R. Identification of a putative gamma-aminobutyric acid (GABA) receptor subunit rho2 cDNA and colocalization of the genes encoding rho2 (GABRR2) and rho1 (GABRR1) to human chromosome 6q14-q21 and mouse chromosome 4. Genomics 1992, 12, 801-806.
33. A receptor gene clusters are derived from an ancestral gene cluster. Genomics 1995, 26, 580-586.
34. Russek, S. J. Evolution of GABA(A) receptor diversity in the human genome. Gene 1999, 227, 213-222.
35. Bailey, M.; Albrecht, B. E.; Johnson, K. J.; Darlison, M. G. Genetic linkage and radiation hybrid mapping of the three human GABA(C) receptor rho subunit genes: GABRR1, GABRR2 and GABRR3. Biochim. Biophys. Acta, Gene Struct. Express. 1999, 1447, 307-312.
36. A receptors and the cytoskeleton. Nature 1999, 397, 69-72.
37. C receptors to the cytoskeleton at retinal synapses. Nature 1999, 397, 66-69.
38. C receptor. Bioorg. Med. Chem. Lett. 1996, 6, 2073-2076.
39. Bormann, J. The 'ABC' of GABA receptors. Trends Pharmacol. Sci. 2000, 21, 16-19.
40. A receptor subunit. Nature 1997, 385, 820-823.
41. Bonnert, T. P.; McKernan, R. M.; Farrar, S.; le, B. B.; Heavens, R. P.; Smith, D. W.; Hewson, L.; Rigby, M. R.; Sirinathsinghji, D.; Brown, N.; Wafford, K. A.; Whiting, P. J. theta, a novel gamma-aminobutyric acid type A receptor subunit. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 9891-9896.
42. A-receptor subtypes really occur in the brain? Trends Neurosci. 1996, 19, 139-143.
43. A-receptor subtypes. Trends Neurosci. 1996, 19, 386.
44. Homanics, G. E.; Ferguson, C.; Quinlan, J. J.; Daggett, J.; Snyder, K.; Lagenaur, C.; Mi, Z. P.; Wang, X. H.; Grayson, D. R.; Firestone, L. L. Gene knockout of the α6 subunit of the γ-aminobutyric acid type A receptor - lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol. Pharmacol. 1997, 51, 588-596.
45. Homanics, G. E.; Delorey, T. M.; Firestone, L. L.; Quinlan, J. J.; Handforth, A.; Harrison, N. L.; Krasowski, M. D.; Rick, C.; Korpi, E. R.; Makela, R.; Brilliant, M. H.; Hagiwara, N.; Ferguson, C.; Snyder, K.; Olsen, R. W. Mice devoid of γ-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 4143-4148.
46. A-receptor assembly in vivo - lessons from subunit mutant mice. Life Sci. 1998, 62, 1611-1615.
47. A receptors. Br. J. Pharmacol. 1997, 120, 741-748.
48. Thompson, S. A.; Arden, S. A.; Marshall, G.; Wingrove, P. B.; Whiting, P. J.; Wafford, K. A. Residues in transmembrane domains I and II determine gamma-aminobutyric acid type A(A) receptor subtype-selective antagonism by furosemide. Mol. Pharmacol. 1999, 55, 993-999.
49. A receptors and inhibitory synaptic currents by the endogenous CNS sleep regulator cis-9,10-octadecenoamide (COA). Br. J. Pharmacol. 1998, 124, 873-882.
50. Yost, C. S.; Hampson, A. J.; Leonoudakis, D.; Koblin, D. D.; Bornheim, L. M.; Gray, A. T. Oleamide potentiates benzodiazepine-sensitive γ-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration. Anesthesia Analgesia 1998, 86, 1294-1300.
51. Kimura, T.; Ohta, T.; Watanabe, K.; Yoshimura, H.; Yamamoto, I. Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptors. Biol. Pharm. Bull. 1998, 21, 224-226.
52. Nabekura, J.; Noguchi, K.; Witt, M. R.; Nielsen, M.; Akaike, N. Functional modulation of human recombinant γ-aminobutyric acid type a receptor by docosahexaenoic acid. J. Biol. Chem. 1998, 273, 11056-11061.
53. Aoshima, H.; Tenpaku, Y. Modulation of GABA receptors expressed in Xenopus oocytes by 13-1-hydoxylinoleic acid and food additives. Biosci. Biochem. Technol. 1997, 61, 2051-2057.
54. 2. Neuropharmacology 1996, 35, 1347-1353.
55. A receptors. Eur. J. Pharmacol. 1998, 349, 115-121.
56. A receptor complex. Eur. J. Pharmacol. 1998, 344, R1-R2.
57. Ye, J. H.; McArdle, J. J. Waglerin-1 modulates γ-aminobutyric acid activated current of murine hypothalamic neurons. J. Pharmacol. Exp. Ther. 1997, 282, 74-80.
58. - current in identified Aplysia neurons. Neurosci. Lett. 1996, 213, 213-215.
59. A receptors to postsynaptic domains by insulin. Nature 1997, 388, 686-690.
60. A, receptors independently of microtubule depolymerization. Neuropharmacology 1998, 37, 383-390.
61. A receptor. NeuroReport 1998, 9, 1089-1092.
62. A receptor function via coactivation of cGMP-dependent kinase and phosphodiesterase. J. Neurosci. 1998, 18, 2342-2349.
63. A-mediated chloride currents in acutely dissociated hippocampal neurons. Anesthesiology 1998, 88, 473-480.
64. Medina, J. H.; Viola, H.; Wolfman, C.; Marder, M.; Wasowski, C.; Calvo, D.; Paladini, A. C. Overview - flavonoids - a new family of benzodiazepine receptor ligands. Neurochem. Res. 1997, 22, 419-425.
65. Medina, J. H.; Viola, H.; Wolfman, C.; Marder, M.; Wasowski, C.; Calvo, D.; Paladini, A. C. Neuroactive flavonoids - new ligands for the benzodiazepine receptors. Phytomedicine 1998, 5, 235-243.
66. A receptors in vitro. Drug Dev. Res. 1997, 41, 99-106.
67. Dekermendjian, K.; Kahnberg, P.; Witt, M. R.; Sterner, O.; Nielsen, M.; Liljefors, T. Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA(A) receptor complex. J. Med. Chem. 1999, 42, 4343-4350.
68. Huang, R. Q.; Fang, M. J.; Dillon, G. H. The tyrosine kinase inhibitor genistein directly inhibits GABA(A) receptors. Mol. Brain Res. 1999, 67, 177-183.
69. Lee, C. M.; Wong, H. N.; Chui, K. Y.; Choang, T. F.; Hon, P. M.; Chang, H. M. Miltirone, a central benzodiazepine receptor partial agonist from a Chinese medicinal herb Salvia miltiorrhiza. Neurosci. Lett. 1991, 127, 237-241.
70. Ozoe, Y.; Akamatsu, M.; Higata, T.; Ikeda, I.; Mochida, K.; Koike, K.; Ohmoto, T.; Nikaido, T. Picrodendrin and related terpenoid antagonists reveal structural differences between ionotropic GABA receptors of mammals and insects. Bioorg. Med. Chem. 1998, 6, 481-492.
71. Nicholson, R. A.; Lees, G.; Zheng, J.; Verdon, B. Inhibition of GABA-gated chloride channels by 12,14-dichlorodehydroabietic acid in mammalian brain. Br. J. Pharmacol. 1999, 126, 1123-1132.
72. A current of hippocampal neurons. Brain Res. 1997, 770, 169-175.
73. A receptors. Neurochem. Res. 1998, 23, 1283-1290.
74. A receptor binding. J. Neur. Transm., Suppl. 1998, 52, 337-342.
75. A current of rat central nervous system neurons. Eur. J. Pharmacol. 1997, 337, 87-94.
76. A receptor by ciprofloxacin and biphenylacetic acid. Br. J. Pharmacol. 1997, 122, 584-590.
77. A receptor-mediated response and its potentiation with felbinac in Xenopus oocytes injected with mouse-brain mRNA - correlation with convulsive potency in vivo. Toxicol. Appl. Pharmacol. 1997, 145, 246-254.
78. A receptor antagonist. NeuroReport 1999, 10, 795-800.
79. Costa, E.; Guidotti, A.; Mao, C. C. Evidence for the involvement of GABA in the action of benzodiazepines. Adv. Biochem. Psychopharmacol. 1975, 14, 113-130.
80. Haefely, W.; Kucsar, A.; Mohler, H.; Lieri, L.; Polc, P.; Schaffner, R. Possible involvement of GABA in the central actions of benzodiazepines. Adv. Biochem. Psychopharmacol. 1975, 14, 131-151.
81. Rogers, C. J.; Twyman, R. E.; Macdonald, R. L. Benzodiazepine and β-carboline regulation of single GABA(A) receptor channels of mouse spinal neurones in culture. J. Physiol. 1994, 475, 69-82.
82. A channel conductance increased by diazepam. Nature 1997, 388, 71-75.
83. Petersen, E. N.; Jensen, L. H.; Honoré, T.; Braestrup, C. Differential pharmacological effects of benzodiazepine receptor inverse agonists. Adv. Biochem. Psychopharmacol. 1983, 38, 57-64.
84. Braestrup, C.; Nielsen, M.; Honoré, T. Benzodiazepine receptor ligands with positive and negative efficacy. Adv. Biochem. Psychopharmacol. 1983, 37, 237-245.
85. 2-adrenoceptor. Nature 1995, 374, 272-276.
86. - currents. Mol. Pharmacol. 1991, 39, 691-696.
87. A receptors. J. Pharmacol. Exp. Ther. 1993, 266, 1018-1028.
88. A receptor subtypes. Mol. Pharmacol. 1993, 43, 240-244.
89. A receptor channels: From subunits to functional entities. Curr. Opin. Neurobiol. 1992, 2, 263-269.
90. A receptor subunits: role of the δ-subunit. J. Neurosci. 1996, 14, 7077-7086.
91. A receptor channels formed by epsilon subunit-containing isoforms. Mol. Pharmacol. 1999, 55, 168-178.
92. Günther, U.; Benson, J. A.; Benke, D.; Fritschy, J.-M.; Reyes, G.; Knoflach, F.; Cretani, F.; Aguzzi, A.; Arigoni, M.; Lang, Y.; Möhler, H.; Luscher, B. Benzodiazepine-insensitive mice generated by targeted disruption of the γ2 subunit gene of γ-aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 7749-7753
93. Mihic, S. J.; Whiting, P. J.; Klein, R. L.; Wafford, K. A.; Harris, R. A. A single amino acid of the human γ-aminobutyric acid type A receptor γ2 subunit determines benzodiazepine efficacy. J. Biol. Chem. 1994, 269, 32768-32773.
94. A receptors. Mol. Pharmacol. 1993, 43, 253-259.
95. Salva, P.; Costa, J. Clinical pharmacokinetics and pharmacodynamics if zolpidem - therapeutic implications. Clin. Pharmacokin. 1995, 29, 142-153.
96. A receptor subtypes. Eur. Neuropsychopharmacol. 1996, 6, 119-125.
97. Mintzer, M. Z.; Griffiths, R. R. Selective effects of zolpidem on human memory functions. J. Psychopharmacol. 1999, 13, 18-31.
98. A receptors using artificial neural networks. J. Med. Chem. 1995, 38, 715-724.
99. A receptors. J. Med. Chem. 1996, 39, 5246-5256.
100. Winkler, D. A.; Burden, F. R. Holographic QSAR of benzodiazepines. Quant. Struct. Act. Relat. 1998, 17, 224-231.
101. A?benzodiazepine receptor subtypes [alpha-x-beta-3-gamma-2 (x = 1-3, 5, and 6)] via comparative molecular field analysis. J. Med. Chem. 1998, 41, 4130-4142.
102. Aligands of dual functionality. J. Med. Chem. 1999, 42, 1123-1144.
103. A receptor isoforms. Can. J. Physiol. Pharmacol. 1998, 76, 909-920.
104. A receptor function by neuroactive steroids. Brain Res. 1999, 819, 75-82.
105. Park-Chung, M.; Wu, F. S.; Farb, D. H. 3-α-Hydroxy-5β-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. Mol. Pharmacol. 1994, 46, 146-150.
106. ffrench-Mullen, J. M.; Danks, P.; Spence, K. T. Neurosteroids modulate calcium currents in hxippocampal CA1 neurons via a pertussis toxin-sensitive G-protein-coupled mechanism. J. Neurosci. 1994, 14, 1963-1977.
107. Baulieu, E. E. Neurosteroids: A novel function of the brain. Psychoneuroendocrinology 1998, 23, 963-987.
108. A receptor subunit expression in the hippocampus. Mol. Cell. Neurosci. 1994, 5, 451-458.
109. A-receptor complexes in the guinea pig isolated ileum. Neurosci. Lett. 1987, 82, 101-106.
110. A antagonist in the guinea-pig isolated ileum. J. Pharm. Pharmacol. 1990, 42, 662-664.
111. Zorumski, C. F.; Mennerick, S. J.; Covey, D. F. Enantioselective modulation of gabaergic synaptic transmission by steroids and benz[e]indenes in hippocampal microcultures. Synapse 1998, 29, 162-171.
112. A receptor pharmacology of enantiomers of dehydroepiandrosterone sulfate, pregnenolone sulfate, and (3α,5β)-3-hydroxypregnan-20-one sulfate. J. Med. Chem. 1998, 41, 2604-2613.
113. A receptor complex reveals that it may act via the picrotoxin site. J. Pharmacol. Exp. Ther. 1997, 282, 827-833.
114. Shen, W. X.; Mennerick, S.; Zorumski, E. C.; Covey, D. F.; Zorumski, C. F. Pregnenolone sulfate and dehydroepiandrosterone sulfate inhibit GABA-gated chloride currents in Xenopus oocytes expressing picrotoxin-insensitive GABA(A) receptors. Neuropharmacology 1999, 38, 267-271.
115. Kerr, D. I. B.; Ong, J. GABA agonists and antagonists. Med. Res. Rev. 1992, 12, 593-636.
116. A receptor complex: electrophysiological studies. In Steroids and Neuronal Activity; Chadwick, D., Widdows, K., Eds.; Wiley: Chichester, 1990; pp 56-71.
117. Edgar, D. M.; Seidel, W. F.; Gee, K. W.; Lan, N. C.; Field, G.; Xia, H. J.; Hawkinson, J. E.; Wieland, S.; Carter, R. B.; Wood, P. L. Ccd-3693 - an orally bioavailable analogue of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat. J. Pharmacol. Exp. Ther. 1997, 282, 420-429.
118. A receptors. J. Med. Chem. 1997, 40, 1668-1681.
119. Monaghan, E. P.; Navalta, L. A.; Shum, L.; Ashbrook, D. W.; Lee, D. A. Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity. Epilepsia 1997, 38, 1026-1031.
120. 35] TBPS binding. J. Pharmacol. Exp. Ther. 1996, 279, 186-193.
121. A-receptor-mediated contractile responses in the guinea-pig isolated ileum. Eur. J. Pharmacol. 1987, 142, 461-464.
122. A receptors. Neuropharmacology 1993, 32, 59-63.
123. Park, C. M.; Malayev, A.; Purdy, R. H.; Gibbs, T. T.; Farb, D. H. Sulfated and unsulfated steroids modulate gamma-aminobutyric acid(A) receptor function through distinct sites. Brain Res. 1999, 830, 72-87.
124. A receptor-mediated chloride uptake. Brain Res. 1998, 790, 334-338.
125. Xue, B. G.; Whittemore, E. R.; Park, C. H.; Woodward, R. M.; Lan, N. C.; Gee, K. W. Partial agonism by 3α,21-dihydroxy-5β-pregnan-20-one at the γ-aminobutyric acid, receptor neurosteroid site. J. Pharmacol. Exp. Ther. 1997, 281, 1095-1101.
126. Cutting, G. R.; Lu, L.; O'Hara, B. F.; Kasch, L. M.; Montrose-Rafizadeh, C.; Donovan, D. M.; Shimada, S.; Antonarakis, S. E.; Guggino, W. B.; Uhl, G. R. Cloning of the γ-aminobutyric acid (GABA) p1 cDNA: a GABA receptor subunit highly expressed in the retina. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 2673-2677.
127. Martineztorres, A.; Vazquez, A. E.; Panicker, M. M.; Miledi, R. Cloning and functional expression of alternative spliced variants of the p1 γ-aminobutyrate receptor. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4019-4022.
128. Zhang, D.; Pan, Z. H.; Zhang, X.; Brideau, A. D.; Lipton, S. A. Cloning of a γ-aminobutyric acid type C receptor subunit in rat retina with a methionine residue critical for picrotoxinin channel block. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 11756-11760.
129. A receptor p2-subunit cDNA. J. Neurochem. 1995, 65, 964-968.
130. Ogurusu, T.; Shingai, R. Cloning of a putative γ-aminobutyric acid (GABA) receptor subunit p3 cDNA. Biochim. Biophys. Acta 1996, 1305, 15-18.
131. Wegelius, K.; Reeben, M.; Rivera, C.; Kaila, K.; Saarma, M.; Pasternack, M. The p1 GABA receptor cloned from rat retina is down-modulated by protons. NeuroReport 1996, 7, 2005-2009.
132. Albrecht, B. E.; Darlison, M. G. Localization of the p1- and p2-subunit messenger RNAs in chick retina by in situ hybridization predicts the existence of γ-aminobutyric acid type C receptor subtypes. Neurosci. Lett. 1995, 189, 155-158.
133. C and p subunit receptors from the white perch retina. Vis. Neurosci. 1997, 14, 843-851.
134. C receptor subunits. NeuroReport 1998, 9, 229-232.
135. Kusama, T.; Wang, T. L.; Guggino, W. B.; Cutting, G. R.; Uhl, G. R. GABA p2 receptor pharmacological profile: GABA recognition site similarities to p1. Eur. J. Pharmacol. 1993, 245, 83-84.
136. Wang, T. L.; Guggino, W. B.; Cutting, G. R. A novel γ-aminobutyric acid receptor subunit (p2) cloned from human retina forms bicuculline-insensitive homooligomeric receptors in Xenopus oocytes. J. Neurosci. 1994, 14, 6524-6531.
137. A subunits specify their selective interaction in vitro. J. Neurochem. 1998, 70, 40-46.
138. C receptor antagonists differentiate between human p1 and p2 receptors expressed in Xenopus oocytes. Eur. J. Pharmacol. 1998, 357, 227-234.
139. Hackam, A. S.; Wang, T. L.; Guggino, W. B.; Cutting, G. R. A 100 amino acid region in the GABA p1 subunit confers robust homooligomeric expression. NeuroReport 1997, 8, 1425-1430.
140. Hackam, A. S.; Wang, T. L.; Guggino, W. B.; Cutting, G. R. The N-terminal domain of human GABA receptor rhol subunits contains signals for homooligomeric and heterooligomeric interaction. J. Biol. Chem. 1997, 272, 13750-13757.
141. Shingai, R.; Yanagi, K.; Fukushima, T.; Sakata, K.; Ogurusu, T. Functional expression of GABA rho 3 receptors in Xenopus oocytes. Neurosci. Res. 1996, 26, 387-390.
142. C receptor p subunits are heterogeneously expressed in the human CNS and form homo- and heterooligomers with distinct physical properties. Eur. J Neurosci. 1999, 11, 41-50.
143. Amin, J. A single hydrophobic residue confers barbiturate sensitivity to gamma-aminobutyric acid type C receptor. Mol. Pharmacol 1999, 55, 411-423.
144. Belelli, D.; Pau, D.; Cabras, G.; Peters, J. A.; Lambert, J. J. A single amino acid confers barbiturate sensitivity upon the GABA rho(1) receptor. Br. J. Pharmacol. 1999, 127, 601-604.
145. Enz, R.; Brandstatter, J. H.; Hartveit, E.; Wassle, H.; Bormann, J. Expression of GABA receptor p1 and p2 subunits in the retina and brain of the rat. Bur. J. Neurosci. 1995, 7, 1495-1501.
146. C receptor p subunits in the mammalian retina. J. Neurosci. 1996, 16, 4479-4490.
147. C receptor p subunits in the cat, goldfish, and chicken retina. J. Comp. Neurol. 1997, 380, 520-532.
148. Ogurusu, T.; Eguchi, G.; Shingai, R. Localization of γ-aminobutyric acid (GABA) receptor p3 subunit in rat retina. NeuroReport 1997, 8, 925-927.
149. C receptor p-subunits in the rat retina. Eur. J. Neurosci. 1998, 10, 115-127.
150. Boue-Grabot, E.; Roudbaraki, M.; Bascles, L.; Tramu, G.; Bloch, B.; Garret, M. Expression of GABA receptor p subunits in rat brain. J. Neurochem. 1998, 70, 899-907.
151. Wegelius, K.; Pasternack, M.; Hiltunen, J. O.; Rivera, C.; Kaila, K.; Saarma, M.; Reeben, M. Distribution of GABA receptor rho subunit transcripts in the rat brain. Eur. J. Neurosci. 1998,10, 350-357.
152. C receptor p1- and p2-subunit genes in avian and rat brain. Eur. J. Neurosci. 1997, 9, 2414-2422.
153. C receptors on mammalian rod bipolar cells. J. Comp. Neurol 1998, 396, 351-365.
154. C feedback at bipolar terminals in the tiger salamander retina. J. Neurophys. 1998, 79, 2171-2180.
155. Lukasiewicz, P. D.; Shields, C. R. A diversity of GABA receptors in the retina. Semin. Cell Dev. Biol. 1998, 9, 293-299.
156. Curtis, D. R.; Duggan, A. W.; Felix, D.; Johnston, G. A. R. Bicuculline and central GABA receptors. Nature 1970, 228, 676-677.
157. Curtis, D. R.; Duggan, A. W.; Felix, D.; Johnston, G. A. R. GABA, bicuculline and central inhibition. Nature 1970, 226, 1222-1224.
158. Curtis, D. R.; Duggan, A. W.; Felix, D.; Johnston, G. A. R. Bicuculline, an antagonist of GABA and synaptic inhibition in the spinal cord of the cat. Brain Res. 1971, 32, 69-96.
159. Curtis, D. R.; Duggan, A. W.; Felix, D.; Johnston, G. A. R.; McLennan, H. Antagonism between bicuculline and GABA in the cat brain. Brain Res. 1971, 33, 57-73.
160. Johnston, G. A. R.; Beart, P. M.; Curtis, D. R.; Game, C. J.; McCulloch, R. M.; Maclachlan, R. M. Bicuculline methochloride as a GABA antagonist. Nature - New Biol. 1972, 240, 219-220.
161. Andrews, P. R.; Johnston, G. A. R. GABA agonists and antagonists. Biochem. Pharmacol. 1979, 28, 2697-2702.
162. Allan, R. D.; Curtis, D. R.; Headley, P. M.; Johnston, G. A. R.; Lodge, D.; Twitchin, B. The synthesis and activity of cis- and trans-2-(aminomethyl) cyclopropanecarboxylic acid as conformationally restricted analogues of GABA. J. Neurochem. 1980, 34, 652-656.
163. Allan, R. D.; Bornstein, J. C.; Curtis, D. R.; Johnston, G. A. R.; Lodge, D. Selective antagonist activity of 5-aminohex-2-enedioic acid on amino acid excitation of cat spinal neurones. Neurosci. Lett. 1980, 16, 17-20.
164. Drew, C. A.; Johnston, G. A. R.; Weatherby, R. P. Bicuculline-insensitive GABA receptors: studies on the binding of (-)-baclofen to rat cerebellar membranes. Neurosci. Lett. 1984, 52, 317-321.
165. Drew, C. A.; Johnston, G. A. R. Bicuculline- and baclofen-insensitive gamma-aminobutyric acid binding to rat cerebellar membranes. J. Neurochem. 1992, 58, 1087-1092.
166. Shimada, S.; Cutting, G.; Uhl, G. R. γ-Aminobutyric acid A or C receptor? γ-Aminobutyric acid p1 receptor RNA induces bicuculline-, barbiturate-, and benzodiazepine-insensitive gamma-aminobutyric acid responses in Xenopus oocytes. Mol. Pharmacol. 1992, 41, 683-687.
167. Qian, H.; Dowling, J. E. Novel GABA responses from rod-driven retinal horizontal cells. Nature 1993, 361, 162-164.
168. C-like receptors on catfish cone-but not rod-driven horizontal cells. J. Neurosci. 1984, 14, 2648-2658.
169. C receptors on hybrid bass retinal bipolar cells. J. Neurophys. 1995, 74, 1920-1928.
170. Lukasiewicz, P. D.; Werblin, F. S. A novel GABA receptor modulates synaptic transmission from bipolar to ganglion and amacrine cells in the tiger salamander retina. J. Neurosci. 1994, 14, 1213-1223.
171. Lukasiewicz, P. D.; Maple, B. R.; Werblin, F. S. A novel GABA receptor on bipolar cell terminals in the tiger salamander retina. J. Neurosci. 1994, 14, 1202-1212.
172. Johnston, G. A.; Stephanson, A. L. Inhibitors of the glial uptake of β-alanine in rat brain slices. Brain Res. 1976, 102, 374-378.
173. Biedermann, B.; Eberhardt, W.; Reichelt, W. GABA uptake into isolated retinal Muller glial cells of the guinea-pig detected electrophysiologically. NeuroReport 1994, 5, 438-440.
174. 3H] alanine release from rat brain slices by cis-4-aminocrotonic acid. J. Neurochem. 1997, 68, 786-794.
175. Kusama, T.; Spivak, C. E.; Whiting, P.; Dawson, V. L.; Schaeffer, J. C.; Uhl, G. R. Pharmacology of GABA p1 and GABA α/β receptors expressed in Xenopus oocytes and COS cells. Br. J. Pharmacol. 1993, 109, 200-206.
176. C receptor antagonists. Eur. J. Pharmacol. 1997, 329, 223-229.
177. C receptor antagonists. Br. J. Pharmacol. 1997, 122, 1551-1560.
178. Rozzo, A.; Ballerini, L.; Nistri, A. Antagonism by (1,2,5,6-tetrahydropyridine-4-yl) methylphosphinic acid of synaptic transmission in the neonatal rat spinal cord in vitro: An electrophysiological study. Neuroscience 1999, 90, 1085-1092.
179. Enz, R.; Bormann, J. A single point mutation decreases picrotoxinin sensitivity of the human GABA receptor p1 subunit. NeuroReport 1995, 6, 1569-1572.
180. Wang, T. L.; Hackam, A. S.; Guggino, W. B.; Cutting, G. R. A single amino acid in γ-aminobutyric acid p1 receptors affects competitive and noncompetitive components of picrotoxin inhibition. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 11751-11755.
181. Creceptors in rat retinal bipolar cells by protein kinase C. J. Physiol. 1994, 481, 325-330.
182. Calvo, D. J.; Miledi, R. Activation of GABA p1 receptors by glycine and β-alanine. NeuroReport 1995, 6, 1118-1120.
183. Bunin, B. A.; Plunkett, M. J.; Ellman, J. A. The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 4708-4712.
184. Marder, M.; Viola, H.; Bacigaluppo, J. A.; Colombo, M. I.; Wasowski, C.; Wolfman, C.; Medina, J. H.; Ruveda, E. A.; Paladini, A. C. Detection of benzodiazepine receptor ligands in small libraries of flavone derivatives synthesized by solution phase combinatorial chemistry. Biochem. Biophys. Res. Commun. 1998, 249, 481-485.
185. Kuntzweiler, T. A.; Arneric, S. P.; Donnellyroberts, D. L. Rapid assessment of ligand actions with nicotinic acetylcholine receptors using calcium dynamics and flipr. Drug Dev. Res. 1998, 44, 14-20.
186. Cunningham, M. D.; Cunningham, S. M. High-throughput functional detection of NMDA receptor activity. NMDA Receptor Protocols 1999, 128, 179-188.
187. Sasaki, K.; Oota, I.; Wada, K.; Inomata, K.; Ohshika, H.; Haga, M. Effects of bilobalide, a sesquiterpene in Ginkgo biloba leaves, on population spikes in rat hippocampal slices. Comp. Biochem. Physiol. C: Comp. Pharmacol. Toxicol. 1999, 124, 315-321.
188. Huong, N.; Matsumoto, K.; Yamasaki, K.; Watanabe, H. Involvement of supraspinal GABA receptors in majonoside-r2 suppression of clonidine-induced antinociception in mice. Life Sci. 1997, 61, 427-436.
189. Armstrong, N.; Sun, Y.; Chen, G. Q.; Gouaux, E. Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature 1998, 395, 913-917.
190. Ortells, M. O.; Barrantes, G. E.; Wood, C.; Lunt, G. G.; Barrantes, F. J. Molecular modelling of the nicotinic acetylcholine receptor transmembrane region in the open state. Protein Eng. 1997, 10, 511-517.
191. Gready, J. E.; Ranganathan, S.; Schofield, P. R.; Matsuo, Y.; Nishikawa, K. Predicted structure of the extracellular region of ligand-gated ion-channel receptors shows sh2-like and sh3-like domains forming the ligand-binding site. Protein Sci. 1997, 6, 983-998.
192. Bliznyuk, A. A.; Gready, J. E. Simple method for locating possible ligand binding sites on protein surfaces. J. Comput. Chem. 1999, 20, 983-988.
193. Sadee, W. Pharmacogenomics. Br. Med. J. 1999, 319, 1286-1290.
194. Evans, W. E.; Relling, M. V. Pharmacogenomics: Translating functional genomics into rational therapeutics [Review]. Science 1999, 286, 487-491.
195. Carulli, J. P.; Artinger, M.; Swain, P. M.; Root, C. D.; Chee, L.; Tulig, C.; Guerin, J.; Osborne, M.; Stein, G.; Lian, J.; Lomedico, P. T. High throughput analysis of differential gene expression. J. Cell. Biochem. 1998.
196. DeLorey, T. M.; Olsen, R. W. GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man. Epilepsy Res. 1999.
197. Amir, R.; Dahle, E.; Toriolo, D.; Zoghbi, H. Y. Candidate gene analysis in Rett syndrome and the identification of 21 SNPs in Xq. Am. J. Med. Genet. 1999, 90, 69-71.
198. Loh, E. W.; Smith, I.; Murray, R.; McLaughlin, M.; McNulty, S.; Ball, D. Association between variants at the GABA(A)beta 2, GABA(A)alpha 6 and GABA(A)gamma 2 gene cluster and alcohol dependence in a Scottish population. Mol. Psychiatry 1999, 4, 539-544.
199. Parsian, A.; Zhang, Z. H. Human chromosomes 11p15 and 4p12 and alcohol dependence: Possible association with the GABRB1 gene. Am. J. Med. Genet. 1999, 88, 533-538.